Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Onur Yazdan BALCIK"'
Autor:
Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Mehmet Ali Nahit Sendur, Yunus Emre Altıntas, Tugba Tuylu, Sedat Yildirim, Sedat Biter, Mehmet Mutlu Kıdı, Ertugrul Bayram, Nargiz Majidova, Ibrahim Vedat Bayoglu, Mehmetcan Atak, Kadriye Baskurt, Sinem Akbas, Ali Alkan, Ayberk Bayramgil, Ferit Aslan, Elif Sahin, Onur Yazdan Balcik, Ahmet Ziya Bayhan, Seray Saray, Erkan Arpaci, Yakup Ergun
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract We aimed to compare FOLFIRI and bevacizumab with FOLFIRI and aflibercept in terms of overall survival (OS), progression-free survival (PFS) and safety in patients with RAS-mutant metastatic colon cancer who progressed after first-line FOLFOX
Externí odkaz:
https://doaj.org/article/b37a215f01c6451b946652f120eabbc8
Autor:
Omer Acar, Onur Yazdan Balcik, Muslih Urun, Tugay Avci, Mustafa Sahbazlar, Atike Pinar Erdogan
Publikováno v:
Heliyon, Vol 10, Iss 19, Pp e38809- (2024)
Objective: The pivotal prognostic determinant for recurrence and survival in surgically treated gastric cancer (GC) patients remains the lymph node status. Despite the adoption of D2 lymph node dissection as the standard approach in recent years, its
Externí odkaz:
https://doaj.org/article/0f816d9d63764c1d8fd593d36e758fad
Autor:
Yusuf ILHAN, Onur Yazdan BALCIK
Publikováno v:
Medicine Science, Vol 12, Iss 2, Pp 527-31 (2023)
Cancer screening programs are carried out worldwide and in our country to diagnose breast cancer in its early stage, before the disease shows any symptoms. In this study, we aimed to evaluate the knowledge, attitudes, and behaviors of non-physician h
Externí odkaz:
https://doaj.org/article/b4adc3ca8a4348fa87cecc4d24e7cdf5
Autor:
Ferhat, Ekinci, Onur Yazdan, Balcik, Bilgin, Demir, Pinar, Gursoy, Ahmet, Ozveren, Atike Pinar, Erdogan
Publikováno v:
Journal of the College of Physicians and Surgeons Pakistan. 32:996-1003
To evaluate the prognostic significance of the new index designed by formulating neutrophil, lymphocyte, and platelet counts in patients with metastatic disease receiving immune checkpoint inhibitors (ICI) and its effect on the immune-related adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1897fc0de1f043b7cea58cfb456204e4
https://doi.org/10.29271/jcpsp.2022.08.996
https://doi.org/10.29271/jcpsp.2022.08.996
Publikováno v:
Türk Uyku Tıbbı Dergisi, Vol 11, Iss 2, Pp 121-128 (2024)
Objective: Breast cancer (BC) is the most frequent cancer among women. Many BC patients suffer from sleep problems, which have a negative impact on their quality of life (QoL). Our study aims to investigate sleep problems in BC patients treated with
Externí odkaz:
https://doaj.org/article/a0dfe2e0d6744a7caeaf06d58bc403a6
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 32(3)
To evaluate prognostic significance of the new index, designed by formulating hemoglobin, albumin, lymphocyte, and platelet (HALP) counts in patients with metastatic renal cell carcinoma (RCC).Descriptive study.Department of Medical Oncology, Celal B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bbed11f7d029c6a7e9783413fd6c135
https://pubmed.ncbi.nlm.nih.gov/35148582
https://pubmed.ncbi.nlm.nih.gov/35148582
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionSeveral prognostic factors have been identified in patients with metastatic bladder cancer (BC). As it is known, older adult patients are prone to nutritional deficiency. The knowledge about nutrition and impact on survival in older patie
Externí odkaz:
https://doaj.org/article/fdbd29f4ad83433ab035c31aab986149
Autor:
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib has been the standard of care in this setting as it improved overall survival (OS) compared to placebo. In rea
Externí odkaz:
https://doaj.org/article/7d19cca4236d429b8424cc6bef6070f5
Autor:
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/3738f873f38f42ca820c7d9a886f1eba